Macquarie Group’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-443
Closed -$8.03K 1703
2025
Q1
$8.03K Buy
+443
New +$7.94K ﹤0.01% 1659
2023
Q2
Sell
-5,700
Closed -$64K 1689
2023
Q1
$64K Sell
5,700
-56,900
-91% -$690K ﹤0.01% 1628
2022
Q4
$829K Sell
62,600
-26,650
-30% -$350K ﹤0.01% 1456
2022
Q3
$1.05M Sell
89,250
-878
-1% -$12K ﹤0.01% 1410
2022
Q2
$1.33M Hold
90,128
﹤0.01% 1409
2022
Q1
$1.74K Hold
90,128
﹤0.01% 1404
2021
Q4
$1.55M Hold
90,128
﹤0.01% 1443
2021
Q3
$1.51M Hold
90,128
﹤0.01% 1470
2021
Q2
$1.21M Hold
90,128
﹤0.01% 1562
2021
Q1
$1.08M Sell
90,128
-416
-0.5% -$5.03K ﹤0.01% 1379
2020
Q4
$1.12M Hold
90,544
﹤0.01% 1284
2020
Q3
$946K Hold
90,544
﹤0.01% 1245
2020
Q2
$1.27M Buy
90,544
+3,644
+4% +$49.6K ﹤0.01% 1139
2020
Q1
$1.02M Hold
86,900
﹤0.01% 1090
2019
Q4
$1.23M Hold
86,900
﹤0.01% 1192
2019
Q3
$916K Buy
86,900
+35,000
+67% +$419K ﹤0.01% 1245
2019
Q2
$756K Buy
+51,900
New +$736K ﹤0.01% 1276
2018
Q3
Sell
-1,100
Closed -$15K 2210
2018
Q2
$15K Buy
+1,100
New +$16.5K ﹤0.01% 2099
2018
Q1
Sell
-25,400
Closed -$360K 2259
2017
Q4
$360K Buy
25,400
+15,200
+149% +$203K ﹤0.01% 1546
2017
Q3
$144K Buy
+10,200
New +$135K ﹤0.01% 1839
2016
Q1
Sell
-40,000
Closed -$422K 1555
2015
Q4
$422K Hold
40,000
﹤0.01% 1206
2015
Q3
$287K Hold
40,000
﹤0.01% 1348
2015
Q2
$723K Hold
40,000
﹤0.01% 1239
2015
Q1
$629K Hold
40,000
﹤0.01% 1234
2014
Q4
$566K Buy
+40,000
New +$601K ﹤0.01% 1243

Other funds holding INVA

Macquarie Group's INVA Position: Q2 2025 in Review

Macquarie Group sold out of Innoviva (INVA) in Q2 2025, closing a stake of 443 shares — an estimated $8.03K sold.

Macquarie Group first reported a position in INVA in Q4 2014 and held it in 25 quarters. The position peaked at $1.55M in Q4 2021. 266 funds tracked by Wall St. Rank hold INVA as of Q2 2025.

  • Macquarie Group reported no remaining Innoviva position as of Q2 2025 after selling out during the quarter.
  • Macquarie Group sold 443 Innoviva shares in Q2 2025, an estimated $8.03K.
  • Macquarie Group first reported a position in Innoviva in Q4 2014 and held it in 25 quarters.
  • Macquarie Group's Innoviva position peaked at $1.55M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Innoviva as of Q2 2025.

Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.